{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:30:42Z","timestamp":1782495042247,"version":"3.54.5"},"reference-count":24,"publisher":"Wiley","issue":"8pt1","license":[{"start":{"date-parts":[[2008,7,10]],"date-time":"2008-07-10T00:00:00Z","timestamp":1215648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2008,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background and Aim:\u2002<\/jats:bold> We used the model for end\u2010stage liver disease (MELD) scoring system to predict the 3\u2010month prognosis of patients with acute\u2010on\u2010chronic liver failure (ACLF) after plasma exchange (PE) and lamivudine treatment, and studied the predictive factors on the prognosis of patients.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> A total of 280 patients treated with lamivudine were randomly divided into PE and control groups. The relationship between mortality and influential factors of patients was studied by univariate and multivariate analysis.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> The mortality (49.4%) of patients in the PE group with a MELD score from 30 to 40 was lower than that (86.1%) of the control group (\u03c7<jats:sup>2<\/jats:sup>\u2003=\u200324.546, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01). The total bilirubin (TBIL) rebound rate of the dead group was significantly higher than that of the survival group (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01). Univariate analysis showed that mortality was significantly related to age (<jats:italic>P<\/jats:italic>\u2003=\u20030.003), treatment method (<jats:italic>P<\/jats:italic>\u2003=\u20030.000), TBIL (<jats:italic>P<\/jats:italic>\u2003=\u20030.010), MELD score (<jats:italic>P<\/jats:italic>\u2003=\u20030.001), international normalised ratio (<jats:italic>P<\/jats:italic>\u2003=\u20030.014), pretreatment HBV\u2010DNA load (<jats:italic>P<\/jats:italic>\u2003=\u20030.000), decline of hepatitis B virus (HBV)\u2013DNA load during therapy (<jats:italic>P<\/jats:italic>\u2003=\u20030.013), encephalopathy (<jats:italic>P<\/jats:italic>\u2003=\u20030.019), and hepatorenal syndrome (<jats:italic>P<\/jats:italic>\u2003=\u20030.026). In multivariate analysis, MELD scores of 30\u201340, treatment method (<jats:italic>P<\/jats:italic>\u2003=\u20030.003), pretreatment HBV\u2010DNA load (<jats:italic>P<\/jats:italic>\u2003=\u20030.009), decline of HBV\u2010DNA load during therapy (<jats:italic>P<\/jats:italic>\u2003=\u20030.016), and encephalopathy (<jats:italic>P<\/jats:italic>\u2003=\u20030.015) were independent predictors of mortality; for MELD scores above 40, only the MELD score (<jats:italic>P<\/jats:italic>\u2003=\u20030.012) was an independent predictive.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> PE significantly decreased the mortality of patients with a MELD score of 30\u201340. For ACLF patients with a MELD score of 30\u201340, a low viral load pretreatment and quick decline of HBV\u2010DNA load are good predictors for the survival with PE and lamivudine treatment.<\/jats:p>","DOI":"10.1111\/j.1440-1746.2008.05484.x","type":"journal-article","created":{"date-parts":[[2008,7,10]],"date-time":"2008-07-10T07:21:14Z","timestamp":1215674474000},"page":"1242-1249","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Prediction value of model for end\u2010stage liver disease scoring system on prognosis in patients with acute\u2010on\u2010chronic hepatitis B liver failure after plasma exchange and lamivudine treatment"],"prefix":"10.1111","volume":"23","author":[{"given":"Jian\u2010Wu","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li\u2010Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong\u2010Hua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu\u2010Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,7,31]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.139.6.670"},{"key":"e_1_2_7_3_2","first-page":"65","article-title":"Are proinflammatory cytokine concentrations reduced by plasma exchange in patients with severe acute hepatic failure?","volume":"109","author":"Nakae H","year":"2001","journal-title":"Res. Commun. Mol. Pathol. Pharmacol"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1159\/000014407"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2005.11.044"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.04510.x"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2004.0983.x"},{"key":"e_1_2_7_8_2","first-page":"643","article-title":"Diagnostic and treatment guidelines for liver failure","volume":"14","author":"Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association and Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association","year":"2006","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"e_1_2_7_9_2","first-page":"329","article-title":"Operating guide for artificial liver support system","volume":"10","author":"The group of the artificial liver of Society of Infectious Diseases and Parasitic Diseases, CMA","year":"2002","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.6.879"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.1.362-364.2001"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200303-361UP"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20703"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033364"},{"key":"e_1_2_7_15_2","first-page":"500","article-title":"Short\u2010term therapeutic effect of lamivudine on patients with severe chronic hepatitis B","volume":"11","author":"Lu HM","year":"2003","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.6.869"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.2.217"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1053\/he.2000.5852"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2002.35927"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20503"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2001.25879"},{"key":"e_1_2_7_22_2","first-page":"1211","article-title":"Multiple regression analysis on the rebound rate of total bilirubin after ALSS and correlation analysis on prognosis","volume":"26","author":"Mai JT","year":"2005","journal-title":"Guangdong Med. J."},{"key":"e_1_2_7_23_2","first-page":"321","article-title":"Evaluation of acute hepatic failure treated at the Department of Medicine III, Kyushu University Hospital: indications for living\u2010donor liver transplantation","volume":"95","author":"Morizono S","year":"2004","journal-title":"Fukuoka Igaku Zasshi"},{"key":"e_1_2_7_24_2","first-page":"410","article-title":"The impact of HBeAg positivity\/negativity and HBV\u2010DNA loads on the prognosis of chronic severe hepatitis B","volume":"14","author":"Sun QF","year":"2006","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"e_1_2_7_25_2","first-page":"120","article-title":"Factors related to the outcome of patients with chronic severe hepatitis B and effectiveness of antivirus therapy","volume":"21","author":"Wu YZ","year":"2007","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1746.2008.05484.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1746.2008.05484.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T07:59:27Z","timestamp":1697356767000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1746.2008.05484.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,31]]},"references-count":24,"journal-issue":{"issue":"8pt1","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["10.1111\/j.1440-1746.2008.05484.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1746.2008.05484.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,31]]},"assertion":[{"value":"2008-07-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}